Products named on the most general payments in 2021
The 50 highest-ranked drugs, biologicals and devices, by general payments for program year 2021, out of $3,011,926,807 of that kind reported across the whole year. A ranking is not a judgement, and this list is a slice of the year rather than all of it.
Ranked by reported value
50 shownDownload CSV · 50 rows Free, no sign-in. Raw amounts in U.S. dollars; the second row says where the data came from.
- Comirnaty 17.1% of the year $516,302,056 · 7 payments
- Tecentriq 1.9% of the year $56,555,455 · 3,074 payments
- Da Vinci Surgical System 1.4% of the year $40,718,567 · 63,381 payments
- Entyvio 1.3% of the year $38,212,191 · 25,878 payments
- Attune 1.2% of the year $36,962,592 · 3,258 payments
- Arthrex 1.1% of the year $32,104,593 · 4 payments
- Arthrex 1.1% of the year $32,104,593 · 4 payments
- Arthrex 1.1% of the year $32,104,593 · 4 payments
- Arthrex 1.1% of the year $32,104,593 · 4 payments
- Arthrex 1.1% of the year $32,104,593 · 4 payments
- Botox 1% of the year $29,507,001 · 37,167 payments
- Imfinzi 0.9% of the year $27,919,065 · 6,344 payments
- Knees-Subchondroplasty 0.9% of the year $26,509,059 · 2 payments
- Accolade 0.8% of the year $24,490,462 · 2,599 payments
- Persona 0.8% of the year $22,847,488 · 1,844 payments
- Ubrelvy 0.7% of the year $20,160,031 · 337,662 payments
- CD Horizon 0.6% of the year $19,227,511 · 3,366 payments
- Triathlon 0.6% of the year $16,901,558 · 3,470 payments
- Cerdelga 0.6% of the year $16,576,813 · 299 payments
- Vraylar 0.5% of the year $16,236,701 · 348,302 payments
- Trident 0.5% of the year $16,181,359 · 751 payments
- Rybelsus 0.5% of the year $15,649,163 · 350,316 payments
- Mako 0.5% of the year $15,035,484 · 18,775 payments
- VNS - Sentiva 0.5% of the year $13,651,807 · 3,954 payments
- Nurtec Odt 0.4% of the year $12,926,401 · 182,672 payments
- Da Vinci Surgical System 0.4% of the year $12,714,217 · 4,933 payments
- Xarelto 0.4% of the year $12,147,342 · 277,081 payments
- Ellipsys 0.4% of the year $11,204,252 · 2,220 payments
- Ocrevus 0.4% of the year $10,945,215 · 6,915 payments
- Reclaim 0.4% of the year $10,601,760 · 190 payments
- Farxiga 0.3% of the year $10,083,216 · 178,073 payments
- Pinnacle 0.3% of the year $9,973,759 · 551 payments
- Keytruda 0.3% of the year $9,942,612 · 23,648 payments
- Jardiance 0.3% of the year $9,681,388 · 154,998 payments
- Arthrex 0.3% of the year $9,585,568 · 44 payments
- Ozempic 0.3% of the year $9,522,074 · 338,661 payments
- Trelegy Ellipta 0.3% of the year $8,816,727 · 175,213 payments
- Arthrex 0.3% of the year $8,713,138 · 8 payments
- Arthrex 0.3% of the year $8,416,573 · 8 payments
- Oxford-Knees 0.3% of the year $8,381,067 · 594 payments
- Arthrex 0.3% of the year $8,284,278 · 4 payments
- Arthrex 0.3% of the year $8,284,278 · 4 payments
- Arthrex 0.3% of the year $8,284,278 · 4 payments
- Summit 0.3% of the year $8,279,477 · 157 payments
- Dupixent 0.3% of the year $8,142,311 · 64,800 payments
- DJO Surgical AltiVate Reverse 0.3% of the year $7,797,120 · 1,238 payments
- Aequalis Perform 0.3% of the year $7,769,330 · 664 payments
- Elekta Medical Linear Accelerator 0.3% of the year $7,714,047 · 181 payments
- Elekta Medical Linear Accelerator 0.3% of the year $7,714,047 · 181 payments
- Elekta Medical Linear Accelerator 0.3% of the year $7,713,899 · 180 payments